- Home
- KLRS vs ISPO Comparison
KLRS vs ISPO Comparison
Compare KLRS & ISPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLRS
- ISPO
- Stock Information
- Founded
- KLRS 2019
- ISPO 2010
- Country
- KLRS United States
- ISPO United States
- Employees
- KLRS N/A
- ISPO N/A
- Industry
- KLRS Biotechnology: Biological Products (No Diagnostic Substances)
- ISPO Blank Checks
- Sector
- KLRS Health Care
- ISPO Finance
- Exchange
- KLRS Nasdaq
- ISPO Nasdaq
- Market Cap
- KLRS 46.0M
- ISPO 37.5M
- IPO Year
- KLRS N/A
- ISPO N/A
- Fundamental
- Price
- KLRS $4.39
- ISPO $3.07
- Analyst Decision
- KLRS Strong Buy
- ISPO
- Analyst Count
- KLRS 2
- ISPO 0
- Target Price
- KLRS $23.00
- ISPO N/A
- AVG Volume (30 Days)
- KLRS 728.6K
- ISPO 155.0K
- Earning Date
- KLRS 11-15-2025
- ISPO 10-27-2025
- Dividend Yield
- KLRS N/A
- ISPO N/A
- EPS Growth
- KLRS N/A
- ISPO N/A
- EPS
- KLRS N/A
- ISPO N/A
- Revenue
- KLRS N/A
- ISPO $261,225,000.00
- Revenue This Year
- KLRS N/A
- ISPO N/A
- Revenue Next Year
- KLRS N/A
- ISPO $148.66
- P/E Ratio
- KLRS N/A
- ISPO N/A
- Revenue Growth
- KLRS N/A
- ISPO N/A
- 52 Week Low
- KLRS $2.14
- ISPO $2.19
- 52 Week High
- KLRS $24.15
- ISPO $7.17
- Technical
- Relative Strength Index (RSI)
- KLRS 58.92
- ISPO 52.43
- Support Level
- KLRS $3.49
- ISPO $2.75
- Resistance Level
- KLRS $5.30
- ISPO $3.19
- Average True Range (ATR)
- KLRS 0.77
- ISPO 0.24
- MACD
- KLRS -0.01
- ISPO 0.01
- Stochastic Oscillator
- KLRS 23.97
- ISPO 42.67
About KLRS Kalaris Therapeutics Inc. Common Stock
Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases. The company is developing TH103, a novel, clinical-stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer-lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body's native, highest affinity VEGF receptor 1.
About ISPO Inspirato Incorporated
Inspirato Inc is a private, luxury hospitality club that provides its members with access to an exclusive portfolio of high-end vacation homes, luxury hotels, and curated travel experiences worldwide. The club offers personalized service, dedicated trip planning, and seamless access to exceptional properties through its innovative model designed to ensure the service, certainty and value that discerning customers demand. The Inspirato portfolio of curated luxury vacation options includes approximately 350 private luxury vacation homes and accommodations at over 220 luxury hotel and resort partners in over 180 destinations around the world.